Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
The Lancet. Global Health
|
September 19, 2018
Essentials of Global Health: a book for students, by students
Anand Bhopal, Daniel Knights, Felicity Knights, et al.
American Journal of Cancer Research
|
March 9, 2022
Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness
Ingrid Espinoza, Chandra Kurapaty, Cheol-Hong Park, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 15, 2015
Risk of Colorectal and Other Cancers in Patients With Serrated Polyposis
Daniel L Edelstein, Marcia Cruz-Correa, Marievelisse Soto-Salgado, et al.
Breast Cancer Research and Treatment
|
January 19, 2008
HER2 in well differentiated breast cancer: is testing necessary?
G Kenneth Haines, Elizabeth Wiley, Barbara Susnik, et al.
Clinical Epigenetics
|
February 18, 2016
DNA methylation and hormone receptor status in breast cancer
Elizaveta V Benevolenskaya, Abul B M M K Islam, Habibul Ahsan, et al.
The Journal of Clinical Investigation
|
January 6, 2006
AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer
Jose V Moyano, Joseph R Evans, Feng Chen, et al.
Cancer Medicine
|
April 9, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
Ticiana A Leal, Marina N Sharifi, Nancy Chan, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
The Lancet. Global Health
|
September 19, 2018
Essentials of Global Health: a book for students, by students
Anand Bhopal, Daniel Knights, Felicity Knights, et al.
American Journal of Cancer Research
|
March 9, 2022
Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness
Ingrid Espinoza, Chandra Kurapaty, Cheol-Hong Park, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 15, 2015
Risk of Colorectal and Other Cancers in Patients With Serrated Polyposis
Daniel L Edelstein, Marcia Cruz-Correa, Marievelisse Soto-Salgado, et al.
Breast Cancer Research and Treatment
|
January 19, 2008
HER2 in well differentiated breast cancer: is testing necessary?
G Kenneth Haines, Elizabeth Wiley, Barbara Susnik, et al.
Clinical Epigenetics
|
February 18, 2016
DNA methylation and hormone receptor status in breast cancer
Elizaveta V Benevolenskaya, Abul B M M K Islam, Habibul Ahsan, et al.
The Journal of Clinical Investigation
|
January 6, 2006
AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer
Jose V Moyano, Joseph R Evans, Feng Chen, et al.
Cancer Medicine
|
April 9, 2022
A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)
Ticiana A Leal, Marina N Sharifi, Nancy Chan, et al.
Page
of 5